Surprisingly, the frequency of spike-specific T regulatory cells (Tregs, CD25+CD39+) was significantly higher in participants with RA on JAK inhibitors than in those on TNF inhibitors, other drugs, or controls (Fig. 4d). Here, ENTPD1 is linked to rheumatoid arthritis.